Skip to main content

SUCCINATO DESHIDROGENASA Y ENFERMEDAD HUMANA: DESCUBRIMIENTOS INESPERADOS SOBRE UNA ENZIMA BIEN CONOCIDA

PID2023-150506OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme

  • Esteban-Amo, María J.
  • Jiménez-Cuadrado, Patricia
  • Serrano-Lorenzo, Pablo
  • Fuente, Miguel A. de la
  • Simarro-Grande, María
Succinate dehydrogenase (also known as complex II) plays a dual role in respiration by catalyzing the oxidation of succinate to fumarate in the tricarboxylic acid (TCA) cycle and transferring electrons from succinate to ubiquinone in the mitochondrial electron transport chain (ETC). Owing to the privileged position of SDH/CII, its dysfunction leads to TCA cycle arrest and altered respiration. This review aims to elucidate the widely documented profound metabolic effects of SDH/CII deficiency, along with the newly unveiled survival mechanisms in SDH/CII-deficient cells. Such an understanding reveals exploitable vulnerabilities for strategic targeting, which is crucial for the development of novel and more precise therapies for primary mitochondrial diseases, as well as for familial and sporadic cancers associated with SDH/CII mutations., The APC was funded by Agencia Estatal de Investigación, Grant Number PID2023-150506OB-I00., Peer reviewed